vs
Amphastar Pharmaceuticals, Inc.（AMPH）とSTRATTEC SECURITY CORP（STRT）の財務データ比較。上の社名をクリックして会社を切り替えられます
Amphastar Pharmaceuticals, Inc.の直近四半期売上が大きい（$183.1M vs $137.5M、STRATTEC SECURITY CORPの約1.3倍）。Amphastar Pharmaceuticals, Inc.の純利益率が高く（13.3% vs 3.6%、差は9.7%）。STRATTEC SECURITY CORPの前年同期比売上増加率が高い（5.9% vs -1.8%）。Amphastar Pharmaceuticals, Inc.の直近四半期フリーキャッシュフローが多い（$24.6M vs $11.3M）。過去8四半期でSTRATTEC SECURITY CORPの売上複合成長率が高い（7.7% vs 3.2%）
Amphastar Pharmaceuticalsは上場されている米国の特殊製薬企業です。2004年5月に設立され、主に吸入剤および鼻腔内投与製品の開発、生産、販売を行っており、特色ある医薬品分野で事業を展開しています。
STRATTECセキュリティコーポレーションは、自動車用機械式・電子式ロック、キー、パッシブエントリーシステムなどのセキュリティアクセス製品を設計・製造・販売しています。主な顧客は世界の自動車OEM、大型車両メーカー、自動車アフターマーケット事業者で、北米、欧州、アジア太平洋地域で事業を展開しています。
AMPH vs STRT — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $183.1M | $137.5M |
| 純利益 | $24.4M | $4.9M |
| 粗利率 | 46.8% | 16.5% |
| 営業利益率 | 19.4% | 3.5% |
| 純利益率 | 13.3% | 3.6% |
| 売上前年比 | -1.8% | 5.9% |
| 純利益前年比 | -35.7% | 275.1% |
| EPS（希薄化後） | $0.51 | $1.20 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $183.1M | $137.5M | ||
| Q3 25 | $191.8M | $152.4M | ||
| Q2 25 | $174.4M | $152.0M | ||
| Q1 25 | $170.5M | $144.1M | ||
| Q4 24 | $186.5M | $129.9M | ||
| Q3 24 | $191.2M | $139.1M | ||
| Q2 24 | $182.4M | — | ||
| Q1 24 | $171.8M | $140.8M |
| Q4 25 | $24.4M | $4.9M | ||
| Q3 25 | $17.4M | $8.5M | ||
| Q2 25 | $31.0M | $8.3M | ||
| Q1 25 | $25.3M | $5.4M | ||
| Q4 24 | $38.0M | $1.3M | ||
| Q3 24 | $40.4M | $3.7M | ||
| Q2 24 | $37.9M | — | ||
| Q1 24 | $43.2M | $1.5M |
| Q4 25 | 46.8% | 16.5% | ||
| Q3 25 | 51.4% | 17.3% | ||
| Q2 25 | 49.6% | 16.7% | ||
| Q1 25 | 50.0% | 16.0% | ||
| Q4 24 | 46.5% | 13.2% | ||
| Q3 24 | 53.3% | 13.6% | ||
| Q2 24 | 52.2% | — | ||
| Q1 24 | 52.4% | 10.4% |
| Q4 25 | 19.4% | 3.5% | ||
| Q3 25 | 13.2% | 6.9% | ||
| Q2 25 | 24.2% | 5.6% | ||
| Q1 25 | 21.9% | 4.9% | ||
| Q4 24 | 24.2% | 1.6% | ||
| Q3 24 | 29.8% | 3.6% | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 27.9% | 1.4% |
| Q4 25 | 13.3% | 3.6% | ||
| Q3 25 | 9.0% | 5.6% | ||
| Q2 25 | 17.8% | 5.4% | ||
| Q1 25 | 14.8% | 3.7% | ||
| Q4 24 | 20.4% | 1.0% | ||
| Q3 24 | 21.1% | 2.7% | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 25.1% | 1.1% |
| Q4 25 | $0.51 | $1.20 | ||
| Q3 25 | $0.37 | $2.07 | ||
| Q2 25 | $0.64 | $2.02 | ||
| Q1 25 | $0.51 | $1.32 | ||
| Q4 24 | $0.74 | $0.32 | ||
| Q3 24 | $0.78 | $0.92 | ||
| Q2 24 | $0.73 | — | ||
| Q1 24 | $0.81 | $0.37 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $282.8M | $99.0M |
| 総負債低いほど良い | $608.7M | — |
| 株主資本純資産 | $788.8M | $236.8M |
| 総資産 | $1.6B | $392.2M |
| 負債/資本比率低いほどレバレッジが低い | 0.77× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $282.8M | $99.0M | ||
| Q3 25 | $276.2M | $90.5M | ||
| Q2 25 | $231.8M | $84.6M | ||
| Q1 25 | $236.9M | $62.1M | ||
| Q4 24 | $221.6M | $42.6M | ||
| Q3 24 | $250.5M | $34.4M | ||
| Q2 24 | $217.8M | — | ||
| Q1 24 | $289.6M | $9.6M |
| Q4 25 | $608.7M | — | ||
| Q3 25 | $608.6M | — | ||
| Q2 25 | $607.7M | — | ||
| Q1 25 | $603.9M | — | ||
| Q4 24 | $601.6M | — | ||
| Q3 24 | $596.4M | — | ||
| Q2 24 | $586.9M | — | ||
| Q1 24 | $594.0M | — |
| Q4 25 | $788.8M | $236.8M | ||
| Q3 25 | $776.7M | $230.5M | ||
| Q2 25 | $757.5M | $221.6M | ||
| Q1 25 | $751.3M | $210.7M | ||
| Q4 24 | $732.3M | $204.5M | ||
| Q3 24 | $727.7M | $203.0M | ||
| Q2 24 | $713.3M | — | ||
| Q1 24 | $672.4M | $193.8M |
| Q4 25 | $1.6B | $392.2M | ||
| Q3 25 | $1.7B | $390.1M | ||
| Q2 25 | $1.6B | $391.5M | ||
| Q1 25 | $1.6B | $387.4M | ||
| Q4 24 | $1.6B | $355.9M | ||
| Q3 24 | $1.5B | $366.9M | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.6B | $348.5M |
| Q4 25 | 0.77× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $32.9M | $13.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.6M | $11.3M |
| FCFマージンFCF / 売上 | 13.4% | 8.2% |
| 設備投資強度設備投資 / 売上 | 4.5% | 1.9% |
| キャッシュ転換率営業CF / 純利益 | 1.35× | 2.81× |
| 直近12ヶ月FCF直近4四半期 | $121.2M | $67.8M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $32.9M | $13.9M | ||
| Q3 25 | $52.6M | $11.3M | ||
| Q2 25 | $35.6M | $30.2M | ||
| Q1 25 | $35.1M | $20.7M | ||
| Q4 24 | $29.0M | $9.4M | ||
| Q3 24 | $60.0M | $11.3M | ||
| Q2 24 | $69.1M | — | ||
| Q1 24 | $55.3M | $-309.0K |
| Q4 25 | $24.6M | $11.3M | ||
| Q3 25 | $47.2M | $9.8M | ||
| Q2 25 | $25.0M | $27.2M | ||
| Q1 25 | $24.4M | $19.6M | ||
| Q4 24 | $16.6M | $8.5M | ||
| Q3 24 | $46.2M | $9.3M | ||
| Q2 24 | $63.1M | — | ||
| Q1 24 | $46.5M | $-2.0M |
| Q4 25 | 13.4% | 8.2% | ||
| Q3 25 | 24.6% | 6.4% | ||
| Q2 25 | 14.3% | 17.9% | ||
| Q1 25 | 14.3% | 13.6% | ||
| Q4 24 | 8.9% | 6.6% | ||
| Q3 24 | 24.1% | 6.7% | ||
| Q2 24 | 34.6% | — | ||
| Q1 24 | 27.1% | -1.4% |
| Q4 25 | 4.5% | 1.9% | ||
| Q3 25 | 2.8% | 1.0% | ||
| Q2 25 | 6.1% | 2.0% | ||
| Q1 25 | 6.3% | 0.8% | ||
| Q4 24 | 6.7% | 0.7% | ||
| Q3 24 | 7.2% | 1.5% | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 5.1% | 1.2% |
| Q4 25 | 1.35× | 2.81× | ||
| Q3 25 | 3.03× | 1.33× | ||
| Q2 25 | 1.15× | 3.65× | ||
| Q1 25 | 1.39× | 3.84× | ||
| Q4 24 | 0.76× | 7.16× | ||
| Q3 24 | 1.48× | 3.06× | ||
| Q2 24 | 1.82× | — | ||
| Q1 24 | 1.28× | -0.21× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
STRT
| Door Handles And Exterior Trim | $35.0M | 25% |
| Power Access Solutions | $34.5M | 25% |
| Keys And Locksets | $26.8M | 19% |
| Latches | $16.3M | 12% |
| User Interface Controls | $12.5M | 9% |
| Aftermarket And Service | $9.4M | 7% |
| Other Product | $3.1M | 2% |
| Related Party | $1.3M | 1% |
